Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |